David Goldenberg, M.D.

David Goldenberg, M.D. is a Head and Neck Surgical Oncologist. He was educated at the Ben Gurion University in Israel. He completed a residency in Otolaryngology-Head and Neck Surgery at Rambam Medical Center in Haifa, Israel and then went on to do a 3-year fellowship in Head and Neck Surgery and Oncology at the Johns Hopkins Hospital in Baltimore, Maryland. Currently the Baron Professor of both Surgery and Oncology at the Penn State University College of Medicine, he also serves as the Chief of Otolaryngology-Head and Neck Surgery at the Penn State Hershey Medical Center. He combines a busy surgical practice with teaching and research. His clinical research focus is on outcomes and etiology of the rise in incidence of thyroid cancer and his basic research lab focuses on thyroid cancer genomics in familial nonmedullary thyroid cancer as well as radiation induced thyroid cancer. He has authored numerous articles and books on head and neck and thyroid oncology and surgery.

Mimi I. Hu, M.D., is an Endocrinologist, Associate Professor, and Deputy Chair of Clinical Operations in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas MD Anderson Cancer Center in Houston, Texas. She graduated from Rice University with a degree in mechanical engineering and obtained her medical degree from the University of Texas – Houston Health Sciences Center. She completed her residency and endocrine fellowship at the Baylor College of Medicine, where she also served as chief medical resident. After completion of her research fellowship at MD Anderson, she joined the faculty in 2007. Dr. Hu’s clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma (differentiated and medullary), hereditary endocrine neoplasia disorders, and metabolic bone and mineral disorders. She has been the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders.

Peter Angelos, M.D., Ph.D., FACS, is the Linda Kohler Anderson Professor of Surgery and Surgical Ethics, Chief of Endocrine Surgery, and Associate Director of the MacLean Center for Clinical Medical Ethics at the University of Chicago. He completed his undergraduate degree, medical school, and a Ph.D. in Philosophy at Boston University. He completed his residency in General Surgery at Northwestern University and went on to complete fellowships in Clinical Ethics at the University of Chicago and in Endocrine Surgery at the University of Michigan. Dr. Angelos is a busy endocrine surgeon who has written widely on improving outcomes of thyroid and parathyroid surgery, minimally invasive endocrine surgery, and ethical aspects in the care of surgical patients. He served as President of the American Association of Endocrine Surgeons 2016-2017.

Lori J. Wirth, M.D., Medical Oncologist, is Assistant Professor in Medicine at Harvard Medical School and at Massachusetts General Hospital, and clinician in the Head and Neck Oncology Program at the Massachusetts General Hospital Cancer Center, all in Boston, Massachusetts, where thyroid tumors are one of her specialties. Dr. Wirth graduated from Brown University and received her M.D. from Columbia University College of Physicians and Surgeons in New York. She completed a residency in Internal Medicine at New York Presbyterian Hospital and then became a fellow in Medical Oncology at the Dana-Farber Cancer Institute. She is a member of the National Cancer Institute’s Metastatic/Recurrent Disease Task Force/Head and Neck Steering Committee, as well as a Thyroid Cancer Guideline Panel Member of the National Comprehensive Cancer Network. Dr. Wirth has given numerous invited presentations at the regional, national, and international levels and has authored numerous publications. She is also a reviewer for medical journals. 

Jennifer A. Sipos, M.D., is Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University College of Medicine, Columbus, Ohio.  Her clinical and research interests are thyroid cancer, general thyroid disorders, and thyroid physiology.  Dr. Sipos has authored numerous journal articles and serves as a member of the National Cancer Institute’s Physician Data Query Cancer Genetics Editorial Board. Following her graduation from medical school, Dr. Sipos completed a residency at Wake Forest University Baptist Medical Center and a fellowship at the University of North Carolina Hospitals. 

Eric J. Sherman, M.D., Oncologist, Memorial Sloan-Kettering Cancer Center, New York City, New York, received his medical training at Columbia University College of Physicians and Surgeons, and did his residencies at New York University/Bellevue Medical Center. After a fellowship at the Memorial Sloan Kettering Cancer Center, he joined the Head and Neck Oncology Service there, where he specializes in thyroid cancer and head and neck cancers. Much of his research focuses on targeted therapy in the treatment of thyroid cancers (differentiated thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer). Dr. Sherman is board certified in internal medicine and medical oncology. 

Yuri E. Nikiforov, M.D., Ph.D. is Vice-Chair for Molecular Pathology and Director, Division of Molecular and Genomic Pathology at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. Dr. Nikiforov oversees the operations of the Molecular and Genomic Pathology laboratory in the Clinical Lab Building; he oversees and participates in clinical sign out in the Division. He also serves at Co-Director, Multidisciplinary Thyroid Center at UPMC. His clinical expertise is in surgical pathology of the thyroid gland and in molecular testing of thyroid other tumors. His research is focused on thyroid cancer genetics and mechanisms of chromosomal rearrangements and other mutations induced by ionizing radiation in thyroid cells and other cell types. He has received the Van Meter Award from the American Thyroid Association, as well as The Endocrine Society;s International Award for Publishing Excellence in The Journal of Clinical Endocrinology & Metabolism.

Barry D. Nelkin Ph.D., is a Laboratory Scientist and Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital in Baltimore, Maryland. His interests include Molecular Mechanisms of Thyroid and Lung Cancers. He received his Ph.D., at George Washington University in Washington, D.C. and completed his postdoctoral fellowship at Johns Hopkins Kimmel Cancer Center.

Joshua P. Klopper, M.D., Endocrinologist, at the Colorado Permanente Medical Group in Denver, CO. His research interests focus on treatment of poorly differentiated thyroid cancer, molecular targets in the nuclear hormone receptor superfamily, activation of retinoid, PPARy, and Vitamin D receptors to inhibit cell growth and potentially induce redifferentiation in aggressive thyroid cancers. He received his medical degree from Emory University School of Medicine, and completed postgraduate training at the University of CO Health Sciences Center. His publication topics include molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules, DNA profiling analysis of human thyroid cancer cell lines, and inhibiting anaplastic thyroid carcinoma tumor growth.

Elizabeth G. Grubbs, M.D., is a Surgeon at the University of Texas MD Anderson Cancer Center, in Houston, Texas. She is also Associate Professor, Department of Surgical Oncology. She earned her M.D. at Duke University School of Medicine in North Carolina, followed by postgraduate training at Duke and at the University of Texas MD Anderson Cancer Center. She is author of numerous peer-reviewed original research articles.